Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3758934013 | Tagraxofusp | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3758935014 | Tagraxofusp (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Tagraxofusp | Is a | Substance with interleukin-3 receptor alpha antagonist mechanism of action (substance) | true | Inferred relationship | Existential restriction modifier | ||
Tagraxofusp | Is a | Recombinant protein | true | Inferred relationship | Existential restriction modifier | ||
Tagraxofusp | Has disposition | Interleukin 3 receptor alpha antagonist | true | Inferred relationship | Existential restriction modifier | ||
Tagraxofusp | Is a | Antineoplastic agent | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing tagraxofusp (medicinal product) | Has active ingredient | True | Tagraxofusp | Inferred relationship | Existential restriction modifier | 1 |
Product containing only tagraxofusp (medicinal product) | Has active ingredient | True | Tagraxofusp | Inferred relationship | Existential restriction modifier | 1 |
Product containing tagraxofusp in parenteral dose form (medicinal product form) | Has active ingredient | True | Tagraxofusp | Inferred relationship | Existential restriction modifier | 1 |
Product containing only tagraxofusp in parenteral dose form (medicinal product form) | Has active ingredient | True | Tagraxofusp | Inferred relationship | Existential restriction modifier | 1 |
This concept is not in any reference sets